QQQ   310.73 (-0.32%)
AAPL   156.60 (+3.83%)
MSFT   262.15 (-0.93%)
META   193.04 (+2.26%)
GOOGL   107.15 (-0.55%)
AMZN   107.79 (-4.53%)
TSLA   195.80 (+4.00%)
NVDA   215.53 (-0.72%)
NIO   11.64 (-2.68%)
BABA   106.89 (-2.60%)
AMD   87.50 (-0.92%)
T   19.83 (-2.22%)
F   13.37 (-6.63%)
MU   63.17 (+0.00%)
CGC   3.04 (-3.18%)
GE   82.84 (-1.31%)
DIS   112.11 (-0.97%)
AMC   6.60 (+8.55%)
PFE   44.11 (-0.52%)
PYPL   87.11 (+0.17%)
NFLX   377.95 (+3.01%)
QQQ   310.73 (-0.32%)
AAPL   156.60 (+3.83%)
MSFT   262.15 (-0.93%)
META   193.04 (+2.26%)
GOOGL   107.15 (-0.55%)
AMZN   107.79 (-4.53%)
TSLA   195.80 (+4.00%)
NVDA   215.53 (-0.72%)
NIO   11.64 (-2.68%)
BABA   106.89 (-2.60%)
AMD   87.50 (-0.92%)
T   19.83 (-2.22%)
F   13.37 (-6.63%)
MU   63.17 (+0.00%)
CGC   3.04 (-3.18%)
GE   82.84 (-1.31%)
DIS   112.11 (-0.97%)
AMC   6.60 (+8.55%)
PFE   44.11 (-0.52%)
PYPL   87.11 (+0.17%)
NFLX   377.95 (+3.01%)
QQQ   310.73 (-0.32%)
AAPL   156.60 (+3.83%)
MSFT   262.15 (-0.93%)
META   193.04 (+2.26%)
GOOGL   107.15 (-0.55%)
AMZN   107.79 (-4.53%)
TSLA   195.80 (+4.00%)
NVDA   215.53 (-0.72%)
NIO   11.64 (-2.68%)
BABA   106.89 (-2.60%)
AMD   87.50 (-0.92%)
T   19.83 (-2.22%)
F   13.37 (-6.63%)
MU   63.17 (+0.00%)
CGC   3.04 (-3.18%)
GE   82.84 (-1.31%)
DIS   112.11 (-0.97%)
AMC   6.60 (+8.55%)
PFE   44.11 (-0.52%)
PYPL   87.11 (+0.17%)
NFLX   377.95 (+3.01%)
QQQ   310.73 (-0.32%)
AAPL   156.60 (+3.83%)
MSFT   262.15 (-0.93%)
META   193.04 (+2.26%)
GOOGL   107.15 (-0.55%)
AMZN   107.79 (-4.53%)
TSLA   195.80 (+4.00%)
NVDA   215.53 (-0.72%)
NIO   11.64 (-2.68%)
BABA   106.89 (-2.60%)
AMD   87.50 (-0.92%)
T   19.83 (-2.22%)
F   13.37 (-6.63%)
MU   63.17 (+0.00%)
CGC   3.04 (-3.18%)
GE   82.84 (-1.31%)
DIS   112.11 (-0.97%)
AMC   6.60 (+8.55%)
PFE   44.11 (-0.52%)
PYPL   87.11 (+0.17%)
NFLX   377.95 (+3.01%)
NYSE:PEN

Penumbra - PEN Stock Forecast, Price & News

$263.81
-1.38 (-0.52%)
(As of 02/3/2023 12:01 PM ET)
Add
Compare
Today's Range
$259.75
$266.15
50-Day Range
$195.94
$265.19
52-Week Range
$114.86
$266.63
Volume
31,359 shs
Average Volume
307,485 shs
Market Capitalization
$10.02 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$245.25

Penumbra MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
7.0% Downside
$245.25 Price Target
Short Interest
Bearish
10.46% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.25
Upright™ Environmental Score
News Sentiment
0.25mentions of Penumbra in the last 14 days
Based on 16 Articles This Week
Insider Trading
Selling Shares
$5.81 M Sold Last Quarter
Proj. Earnings Growth
600.00%
From $0.14 to $0.98 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.08 out of 5 stars

Medical Sector

463rd out of 1,029 stocks

Surgical & Medical Instruments Industry

50th out of 107 stocks

PEN stock logo

About Penumbra (NYSE:PEN) Stock

Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It offers neurovascular thrombectomy and embolization and access technologies, neurosurgical tools, Penumbra LANTERN Delivery Microcatheter, and Penumbra Occlusion Device (POD) system. Its target markets include interventional neuroradiologists, neurosurgeons, neurologists, cardiologists, radiologists, and vascular surgeons. The company was founded by Arani Bose and Adam Elsesser on June 21, 2004, and is headquartered in Alameda, CA.

Receive PEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Penumbra and its competitors with MarketBeat's FREE daily newsletter.

PEN Stock News Headlines

Penumbra (NYSE:PEN) PT Raised to $285.00
Elon Musk Claims Solar Will Soon Power the World
The world's wealthiest person -- Elon Musk -- is a visionary investor. And he fully expects solar power to be our #1 energy source within a few decades. Utility-scale solar is already becoming the cheapest option for electricity generation globally. So with the push toward clean, renewable energy, it's no wonder solar is also becoming one of the fastest growing sectors in the U.S. stock market.
Penumbra (NYSE:PEN) Hits New 1-Year High Following Analyst Upgrade
Penumbra, Inc. (NYSE:PEN) Director Don W. Kassing Sells 693 Shares
Penumbra (NYSE:PEN) PT Raised to $270.00
Piper Sandler Initiates Coverage on Penumbra (NYSE:PEN)
Know Your Profit Potential BEFORE You Trade!
I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! pixel
Penumbra (PEN) Tops Q3 Earnings and Revenue Estimates
See More Headlines
Receive PEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Penumbra and its competitors with MarketBeat's FREE daily newsletter.

PEN Company Calendar

Last Earnings
8/09/2021
Today
2/03/2023
Next Earnings (Confirmed)
2/23/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Employees
3,800
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$245.25
High Stock Price Forecast
$285.00
Low Stock Price Forecast
$185.00
Forecasted Upside/Downside
-7.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
13 Analysts

Profitability

Net Income
$5.28 million
Pretax Margin
-5.32%

Debt

Sales & Book Value

Annual Sales
$747.59 million
Cash Flow
$1.17 per share
Book Value
$25.53 per share

Miscellaneous

Free Float
35,890,000
Market Cap
$10.02 billion
Optionable
Optionable
Beta
0.50

Key Executives

  • Adam ElsesserAdam Elsesser
    Chairman, President & Chief Executive Officer
  • Ben Sorci
    Executive Vice President-Operations
  • Maggie S. Yuen
    Chief Financial Officer
  • Pankaj Tiwari
    Chief Information Officer & Executive VP
  • Michaella Corso
    Vice President-Clinical Affairs













PEN Stock - Frequently Asked Questions

Should I buy or sell Penumbra stock right now?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Penumbra in the last twelve months. There are currently 13 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" PEN shares.
View PEN analyst ratings
or view top-rated stocks.

What is Penumbra's stock price forecast for 2023?

13 Wall Street research analysts have issued 12-month target prices for Penumbra's stock. Their PEN share price forecasts range from $185.00 to $285.00. On average, they predict the company's stock price to reach $245.25 in the next year. This suggests that the stock has a possible downside of 7.5%.
View analysts price targets for PEN
or view top-rated stocks among Wall Street analysts.

How have PEN shares performed in 2023?

Penumbra's stock was trading at $222.46 at the beginning of the year. Since then, PEN stock has increased by 19.2% and is now trading at $265.19.
View the best growth stocks for 2023 here
.

When is Penumbra's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our PEN earnings forecast
.

How can I listen to Penumbra's earnings call?

Penumbra will be holding an earnings conference call on Thursday, February 23rd at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Penumbra's earnings last quarter?

Penumbra, Inc. (NYSE:PEN) posted its quarterly earnings data on Monday, August, 9th. The company reported $0.21 EPS for the quarter, topping the consensus estimate of $0.19 by $0.02. The company earned $184.26 million during the quarter, compared to analysts' expectations of $170.77 million. Penumbra had a negative net margin of 3.68% and a positive trailing twelve-month return on equity of 0.45%. The firm's revenue for the quarter was up 75.3% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.30) EPS.

What guidance has Penumbra issued on next quarter's earnings?

Penumbra issued an update on its FY 2022 earnings guidance on Thursday, November, 10th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $840.00 million-$845.00 million, compared to the consensus revenue estimate of $860.97 million.

What is Adam Elsesser's approval rating as Penumbra's CEO?

57 employees have rated Penumbra Chief Executive Officer Adam Elsesser on Glassdoor.com. Adam Elsesser has an approval rating of 88% among the company's employees.

What other stocks do shareholders of Penumbra own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Penumbra investors own include NVIDIA (NVDA), Intuitive Surgical (ISRG), AbbVie (ABBV), Tesla (TSLA), Alibaba Group (BABA), Johnson & Johnson (JNJ), Netflix (NFLX), UnitedHealth Group (UNH), Boeing (BA) and DexCom (DXCM).

What is Penumbra's stock symbol?

Penumbra trades on the New York Stock Exchange (NYSE) under the ticker symbol "PEN."

Who are Penumbra's major shareholders?

Penumbra's stock is owned by many different institutional and retail investors. Top institutional investors include Baillie Gifford & Co. (3.32%), Allspring Global Investments Holdings LLC (0.44%), New York State Common Retirement Fund (0.20%), AEGON ASSET MANAGEMENT UK Plc (0.18%), New York State Teachers Retirement System (0.09%) and Oak Harbor Wealth Partners LLC (0.09%). Insiders that own company stock include Adam Elsesser, Arani Bose, Bridget O'rourke, Don W Kassing, Don W Kassing, Harpreet Grewal, James Robert Pray, Johanna Roberts, Lynn Rothman, Sridhar Kosaraju, Surbhi Sarna and Thomas Wilder.
View institutional ownership trends
.

How do I buy shares of Penumbra?

Shares of PEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Penumbra's stock price today?

One share of PEN stock can currently be purchased for approximately $265.19.

How much money does Penumbra make?

Penumbra (NYSE:PEN) has a market capitalization of $10.07 billion and generates $747.59 million in revenue each year. The company earns $5.28 million in net income (profit) each year or ($0.82) on an earnings per share basis.

How many employees does Penumbra have?

The company employs 3,800 workers across the globe.

How can I contact Penumbra?

Penumbra's mailing address is One Penumbra Place, Alameda CA, 94502. The official website for the company is www.penumbrainc.com. The company can be reached via phone at (510) 748-3200, via email at investors@penumbrainc.com, or via fax at 510-748-3232.

This page (NYSE:PEN) was last updated on 2/3/2023 by MarketBeat.com Staff